Suppliers / Central Glass Co.,Ltd

Central Glass Co.,Ltd

Japan Updated 9 July 2026

Central Glass Co.,Ltd is an API manufacturer based in Japan. It holds 2 active US drug master files. Its filings concentrate with EEC_EAEU and NCELS (KZ). Its GMP standing is certified by ZLG (DE) and US FDA. Its most recent recorded inspection, by US FDA, closed on 15 September 2023 as VAI.

2
active US DMFs
0
valid CEPs
2
registered plants 1 with an FDA FEI number
9
filings across 2 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
1 of 1 confirmed
Inspections
5 of 5 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026.

Inspection history

  • 15 September 2023 VAI US FDA
  • 29 June 2018 VAI US FDA
  • 19 September 2014 VAI US FDA
  • 9 February 2012 VAI US FDA
  • 24 July 2009 VAI US FDA

NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.

Registered plants

Site FDA FEI
Halle-Kuensebeck, Germany Not on file
Japan, Japan 3002806649

What they file, and where

Molecule Regulators Docs
Sevoflurane US FDA 2

Also appears on these molecule pages

Sevoflurane API

Filings and GMP by regulator

Regulator Filings GMP certificates
EEC_EAEU 8 None
NCELS (KZ) 1 None
ZLG (DE) None 2
US FDA None 1

Questions about Central Glass Co.,Ltd

Does Central Glass Co.,Ltd hold a US DMF or a CEP?
Central Glass Co.,Ltd holds 2 active US drug master files. A drug master file is a submission to the FDA describing how an ingredient is made; a CEP is the EDQM's certificate that the substance meets its European Pharmacopoeia monograph. Both are filings rather than approvals.
Is Central Glass Co.,Ltd FDA-registered?
One site operated by Central Glass Co.,Ltd carries an FDA establishment identifier (FEI), which means it is registered with the FDA as a drug establishment. Registration is not the same as approval or inspection clearance.
How did Central Glass Co.,Ltd's last inspection go?
The most recent inspection on record closed on 15 September 2023 as VAI (Voluntary Action Indicated: issues were found but did not warrant regulatory action). 5 inspections are on file.
Where does Central Glass Co.,Ltd manufacture?
2 registered sites are on record, in Germany and Japan (Halle-kuensebeck and Japan). Every site is listed on this page with the register it came from.
What does Central Glass Co.,Ltd make?
1 molecule is on record against Central Glass Co.,Ltd, including Sevoflurane. Each links through to that molecule's full manufacturer list.
Which regulators recognise Central Glass Co.,Ltd's GMP?
Current GMP certificates are on record from ZLG (DE) and US FDA. GMP recognition covers the manufacturing site, separately from any filing on the substance itself.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Central Glass Co.,Ltd comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Open risk flags

  • The most recent inspection outcome was VAI, on 15 September 2023.

Comparable suppliers

Shandong New Time Pharmaceutical shares 1 molecule Supriya Lifescience shares 1 molecule Jiangsu Hengrui shares 1 molecule Hebei Yipin Pharmaceutical shares 1 molecule Blue Zone Technologies shares 1 molecule

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates